Cyntellect, Inc. Expands Existing Partnership in Japan to Include Distribution of Celigo(TM) Adherent Cell Cytometer
7/13/2010 10:25:09 AM
SAN DIEGO--(BUSINESS WIRE)--Cyntellect, Inc., a privately-held life sciences company commercializing products to advance the study of cell biology, stem cell research, biopharmaceutical production, and drug discovery, today announces the availability of the Celigo™ Adherent Cell Cytometer in Japan. Celigo is the Company’s proven platform for non-invasive in situ live cell imaging, providing unsurpassed speed, flexibility and precision of cellular analysis across a wide range of applications. Today’s announcement follows Cyntellect’s recent distribution deals covering China, Taiwan, South Korea, Singapore, Malaysia and Thailand.